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The TonB system couples cytoplasmic membrane protonmotive force to TonB-gated outer by an amino terminal globular domain called the cork (37).
51
In addition to the TonB-gated transporters in the outer membrane, the TonB system all three proteins form a complex in the CM, but the stoichiometry of this complex is unknown 59 (2, 38). The cellular ratio of TonB:ExbD:ExbB is 1:2:7 (16).
60
The only step in TonB energization known to require the pmf is characterized by a 61 formaldehyde crosslinkable interaction between TonB and ExbD periplasmic domains. While 62 both ExbD and TonB are conformationally responsive to changes in pmf, the absence of 63 protonatable residues in the TonB TMD, among other data, suggests that TonB only responds to 64 pmf by virtue of TonB-ExbD interactions through their periplasmic domains (5, 11, 29, 38, 45). To construct pKP1005, pKP1011, pKP1017, and pKP1023, forward and reverse primers 97 were designed to amplify the last 22 codons of exbB through the stop codon of exbD from a 98 pKP885 (exbB, exbD K97C), pKP899 (exbB, exbD F103C), pKP905 (exbB, exbD T109C), or 99 pKP911 (exbB, exbD L115C) template respectively, introducing flanking NcoI sites. The PCR-100 amplified, NcoI-digested fragment was cloned into the unique NcoI site in pPro24 (34). Proper 
Media and culture conditions 105
Luria-Bertani (LB), tryptone (T), and M9 minimal salts were prepared as previously 106 described (35, 44). Liquid cultures and agar plates were supplemented with 100 μg ml -1 107 ampicillin and plasmid-specific levels of sodium propionate, pH 8, as needed for expression of 108 ExbD (Table S1 ). When coexpression of plasmid-encoded TonB(C18G, A150C) was examined, 109 cultures and agar plates were also supplemented with 34 μg ml -1 chloramphenicol and plasmid- initial rate of transport at about 80% the rate of wild-type plasmid-encoded ExbD (Fig. 2 C) .
220
The 80% activity of ExbD I102C, for which monomer was not detected, suggested that
221
ExbD was active as a homodimer ( Fig. 2A ). ExbD G96C, K108C, and Y112C also had 222 significant levels of disulfide-linked dimers present ( Fig. 2 A, B ). Dimers observed here for than native ExbD levels and exhibited dimer levels equal to or greater than monomers, supported 227 110% and 90% activity, respectively (Fig 2 B) . When inducer was decreased to achieve the 228 desired native ExbD levels of expression for these substitutions, significantly less dimer was 229 present for K108C and activity was the same, near 110%. Y112C now showed equal dimer and 230 monomer levels and activity decreased to 80% (Fig. 2 C) . The activity of these substitutions 231 could be attributed to the significant level of monomer present.
232
ExbD homodimers differentially affect ExbD activity
233
To increase the ratio of dimer to monomer so that the activity of the dimer could be The degree of dimer formation could only be gauged by the decrease in monomer levels.
241
This was due to the fact that, although treated and untreated samples came from the same culture, 242 the detectability of ExbD in the dimer band had greatly increased--exemplified by D111C, TonB A150C required D25 (Fig. 7) . In the presence of wild-type TonB, ExbD D25N cys 360 homodimers were increased compared to substitutions with a wild-type TMD, as expected if 361 disulfide-linked homodimer formation prevented subsequent interactions with TonB (Fig. S2) .
362
In studies of these same substitutions with the co-expression of TonB A150C, the differences 363 between ExbD cys and ExbD D25N cys homodimers were not as obvious. (Fig. 7) . Disulfide- periplasmic domain to these specific heterodimeric associations with the TonB carboxy terminus.
418
The specific signal that initiates the transition is unknown.
419
The theme of homodimeric to heterodimeric transitions involving shared interfaces has 
444
When all sites of spontaneous in vivo disulfide-linked dimer formation in this study were 445 mapped onto the ExbD periplasmic domain NMR structure, homo-dimerization sites clustered at 446 both ends of the structure (Fig. 8) encoded ExbD variants near native ExbD levels (see Table S1 for induction levels) were 661 resolved on non-reducing or reducing 15% SDS-polyacrylamide gels and immunoblotted with 
